Celladon Announces Results of Special Meeting
March 21, 2016 16:05 ET
|
Celladon Corporation
SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that, based upon the final vote count certified by the independent inspector of elections for the...
ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger
March 09, 2016 16:05 ET
|
Celladon Corporation
SAN DIEGO, March 09, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that Institutional Shareholder Services ("ISS") and Glass Lewis & Co., two of the leading...
Celladon Sets Date for Special Meeting of Stockholders
February 10, 2016 16:57 ET
|
Celladon Corporation
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the proposed...
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
November 18, 2015 22:36 ET
|
Celladon Corporation
--Celladon-Eiger Proposed Merger Creates a Biopharmaceutical Company With Diverse Portfolio of Four Novel Drug Development Programs Addressing Orphan Diseases-- --Concurrent Financing of $39.5...
Celladon Reports Second Quarter 2015 Financial Results
August 11, 2015 16:15 ET
|
Celladon Corporation
SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), today announced financial results for the quarter ended June 30, 2015 and recent corporate updates.
Second Quarter...
Celladon Corporation Provides Business Update
June 26, 2015 06:00 ET
|
Celladon Corporation
Process of Seeking Merger or Sale Underway
Company Not Pursuing Further Development of Existing Programs
SAN DIEGO, June 26, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN),...
Celladon Corporation Announces Strategic Direction Following Review of CUPID2 Data
June 01, 2015 07:00 ET
|
Celladon Corporation
-- Company to Seek Acquisition or Partnership --
-- Wedbush PacGrow Healthcare Securities Retained as Exclusive Financial Advisor --
-- Paul Cleveland Named Chief Executive Officer --
SAN...
Celladon Reports First Quarter 2015 Financial Results
May 14, 2015 16:30 ET
|
Celladon Corporation
SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Reports Negative Results for CUPID2 Trial of MYDICAR(R) in Advanced Heart Failure
April 26, 2015 16:40 ET
|
Celladon Corporation
- Investigational gene therapy fails to meet primary and secondary endpoints -
- Investor conference call and webcast Monday at 8:30 a.m. ET (5:30 a.m. PT) -
SAN DIEGO, April 26, 2015 (GLOBE...
Celladon Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights
March 30, 2015 16:05 ET
|
Celladon Corporation
CUPID2 Topline Data Release on Track for Late April
Conference Call March 31, 2015 at 8:30 a.m. Eastern Time
SAN DIEGO, March 30, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a...